|
Active substance |
givosiran |
|
Holder |
Alnylam Netherlands B.V. |
|
Status |
Closed |
|
Indication |
treatment of acute hepatic porphyria (AHP) in adults and adolescents (≥12 years of age). |
|
Public documents |
|
|
Last update |
28/06/2021 |
Givlaari®
Last updated on